CE-22
Safety of
Ranolazine
§Extent of exposure
–2783
subjects/patients
–1714 subject/patient yr
§Adverse events are
generally dose dependent and manageable by typical dose
titration
§No
evidence for an adverse effect of ranolazine on survival